Christine Gebski, See Remarks at REPLIGEN CORP (RGEN), sold 7,576 shares at $147.13 ($1.1M) on 2023-11-10, disclosed to the SEC on 2023-11-13.
Open-market sale of $1.1M RGEN by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $147.13 | 3,788 | $557K | 50.0% |
| 2 | $147.13 | 3,788 | $557K | 50.0% |
| Total | $147.13 avg | 7,576 | $1.1M | 100% |
| Filing → |
| RGEN | SELL | 2021-05-18 | $153K | — | Filing → |
| RGEN | SELL | 2021-03-18 | $276K | — | Filing → |